a r t I C l e S Episodic hippocampal-dependent memory loss, the earliest clinical sign of Alzheimer's disease, is thought to be a result of changes in synaptic function rather than neuronal loss 1, 2 . Specifically, functional brain imaging studies have found hippocampal mild abnormalities before clinical diagnosis and in the absence of structural brain atrophy, suggesting an altered functional connectivity of the hippocampus at early stages of disease [3] [4] [5] .
Dendritic spines are likely to be the first affected synaptic elements during early cognitive decline 6 . This is supported by several lines of evidence: hippocampal spine-mediated plasticity underlies learning and memory 7 , post-mortem hippocampus from Alzheimer patients shows a substantial decrease in dendritic spine density compared with age-matched controls 8 and transgenic mice expressing mutated forms of the amyloid precursor protein (APP), associated with familial Alzheimer's disease, show age-dependent reductions in spine density before plaque deposition 9 . Nevertheless, the molecular link between APP mutations triggering Alzheimer's disease and the occurrence of early spine loss remains elusive. Notably, a localized caspase-3 activity that causes synaptic failure has been observed in vitro 10 , but the molecular mechanism linking caspase-3 activity to synaptic loss is far from being elucidated.
We analyzed caspase-3 activity in hippocampal synapses of the Tg2576 transgenic mouse model, which harbors the human APPswe mutant allele linked to familial Alzheimer's disease 11 . These mice develop early synaptic deficits 12 and several neuropathological features at an older age, including amyloid plaques and dystrophic neurites 13 . Although Tg2576 mice lack neurofibrillary tangles and substantial neuronal loss 14 , there is strong evidence that accumulation of the amyloid-β (Aβ) peptide, derived via APP proteolysis, is responsible for age-related memory decline in this model [15] [16] [17] .
We found that caspase-3 activity increased in Tg2576 hippocampal synapses at 3 months of age, before amyloid plaque deposition is detectable 11 . This enhanced local caspase-3 activity led to a permanent activation of calcineurin, which caused AMPA receptor (AMPAR) GluR1 subunit dephosphorylation and its removal from the postsynaptic sites. Furthermore, we found that this caspase-3 activity increase was matched by a deficit in hippocampal-dependent contextual fear conditioning (CFC), a reduction of spine density in CA1 pyramidal neurons, an alteration in basic glutamatergic synaptic transmission and enhanced long-term depression (LTD) in these same neurons. Notably, pharmacological inhibition of caspase-3 activity in Tg2576 mice restored postsynaptic density (PSD) composition, glutamatergic synaptic transmission and spine size, and partially rescued memory during CFC. Collectively, our data indicate that caspase-3 activity is crucial for the early synaptic dysfunction reported during Alzheimer pathology in Tg2576 mice.
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RESULTS

Onset of memory decline in Tg2576 mice
We evaluated hippocampal-dependent memory in Tg2576 mice and their wild-type controls using the CFC task 18, 19 . We observed that, although wild-type and Tg2576 mice exhibited similar baseline activity during the training trials before the shock delivery ( Supplementary Fig. 1 ), memory performance, as assessed by freezing behavior on re-exposure of mice to the context in which they were previously shocked, was reduced in Tg2576 mice compared with wild-type mice (Fig. 1a) . Notably, this effect reached statistical significance at 3 (P = 0.009), but not at 2 (P > 0.05), months of age, suggesting that the onset of hippocampaldependent memory impairment occurs at 3 months.
To assess whether early cognitive decline in Tg2576 mice was associated with dendritic spine alterations, we measured spine density and spine size in Golgi-stained CA1 pyramidal neurons of the dorsal hippocampus in 2-and 3-month-old wild-type and Tg2576 mice (Fig. 1b) . The number of spines along basal dendrites laying in the stratum oriens was unaltered in Tg2576 mice at both 2 and 3 months of age. In apical dendrites in the stratum radiatum, we detected a reduction in spine density in 3-month-old Tg2576 mice compared with both wild-type littermates and 2-month-old Tg2576 mice (Fig. 1c) . Along the same apical dendrites, Tg2576 mice had a higher proportion of spines with smaller head diameters (Fig. 1d) and the total dendrite length was also reduced (Fig. 1e ) in 3-month-old Tg2576 mice (1,429.10 ± 97.10 µm) compared with age-matched wild-type mice (2,057.99 ± 195.30 µm). Altogether, these alterations resulted in a reduced synaptic input in the hippocampus of Tg2576 mice that likely contributes to their cognitive impairment.
Detection of early synaptic deficits in Tg2576 mice
Structural modifications in the PSD precede morphological alterations of the dendritic spine 20 . To investigate the molecular basis of dendritic spine loss in Tg2576 mice we evaluated the PSD composition in wildtype and Tg2576 mice at 3 months of age. Isolated PSD preparation extracts from hippocampi of Tg2576 and age-matched wild-type mice were blotted and probed with antibodies to the main PSD components ( Fig. 2a and Supplementary Fig. 2a,b) . Although the relative amounts of most postsynaptic components remained essentially unchanged in PSDs from both genotypes, the levels of the AMPAR subunit GluR1 and one of its phosphorylated form (GluR1pSer845) were considerably reduced in the PSD obtained from Tg2576 mice compared with wild type (Fig. 2a) . However, the GluR1 levels were unaffected in total hippocampal homogenates, whereas GluR1pSer845 levels were reduced in Tg2576 hippocampus (Fig. 2b) . Furthermore, the subcellular distribution of GluR1 was also markedly changed in Tg2576 mice, with a decrease in the PSD-enriched fraction (TxP) and an increase in the microsome-enriched fraction ( Fig. 2c and Supplementary Fig. 2c ). Altogether, these results argue against a global degradation of GluR1 in the whole hippocampus of Tg2576 mice and instead suggest a synaptic redistribution of GluR1 and specific dephosphorylation of serine 845.
As it has been shown that Aβ impairs synaptic plasticity 21 , we asked whether modulating Aβ load in Tg2576 mice could affect GluR1 distribution. We intra-hippocampally injected the γ-secretase inhibitor DAPT into 3-month-old Tg2576 mice and found that there was a marked translocation of GluR1 to the PSD-enriched fraction in the DAPT-injected ipsilateral side, as compared with the vehicle-injected contralateral hippocampus 15 h after injection ( Supplementary  Fig. 3a) . We also found that the head diameter of dendritic spines was enlarged in the DAPT-injected ipsilateral side, as compared with the vehicle-injected contralateral hippocampus (Supplementary Fig. 3b) . Finally, bilateral injection of DAPT in the hippocampus of Tg2576 mice 15 h before training appreciably rescued memory deficits without affecting motor activity ( Supplementary Fig. 3c,d ). Together with previous in vitro studies 22 , these results suggest that Aβ contributes to synaptic modifications, as alterations in GluR1 distribution and dendritic spine alterations were blocked by γ-secretase-dependent APP processing inhibition.
Alterations of the PSD composition of hippocampal neurons in 3-month-old Tg2576 mice may lead to changes in glutamatergic synaptic transmission. We first evaluated basic synaptic transmission by measuring the input-output relationships of field excitatory postsynaptic potentials (fEPSPs) of CA1 pyramidal neurons evoked by stimulation of the Schaffer collateral pathway from acute hippocampal slices obtained from wild-type and Tg2576 mice. No difference was detected between Tg2576 and wild-type mice (Supplementary Fig. 4 ). Figure 1 CFC performance and morphology of CA1 neuron dendrites in Tg2576 and wild-type mice. (a) Percentage of freezing time during CFC test in wild-type (WT) and Tg2576 (Tg) mice at 2 and 3 months of age. Data are expressed as mean ± s.e.m. **P < 0.01 (n = 10 mice for each age and genotype). (b) Left, representative photomicrograph of a Golgi-stained section of the dorsal hippocampus. Scale bar represents 100 µm. Right, representative segments of basal and apical dendrites of CA1 hippocampal neurons in 3-month-old wild-type and Tg2576 mice. Scale bar represents 10 µm. (c) Spine density is expressed as the mean spine number per 1-µm dendrite segment ± s.e.m. *P < 0.05, ***P < 0.001 (n = 6 mice for each genotype at 2 months of age, 10 wild-type mice at 3 months of age and 8 Tg2576 mice at 3 months of age; 11 neurons from each mouse). a r t I C l e S To detect more subtle alterations in synaptic transmission, we carried out whole-cell patchclamp recordings of CA1 pyramidal neurons. As the main alteration in the PSD of 3-monthold Tg2576 mice was a downregulation of GluR1 levels, with the levels of NMDA receptor (NMDAR) subunits remaining relatively stable, we first assessed the relative contribution of AMPARs and NMDARs to evoked excitatory postsynaptic currents (EPSCs), measured as an AMPA/NMDA ratio. We found that this ratio was decreased in Tg2576 mice (wild type, 39.34 ± 6.76; Tg2576, 20.24 ± 4.64; Fig. 3a) . We evaluated presynaptic release short-term plasticity by measuring the pairedpulse ratio (PPR) of synaptic responses. The PPR did not differ in Tg2576 (1.42 ± 0.19) and wild-type (1.40 ± 0.07) mice, arguing against any alterations in presynaptic release properties at this age (Fig. 3b) . We also examined AMPAR transmission by measuring spontaneous miniature excitatory postsynaptic currents (mEPSCs), which represent AMPAR-mediated postsynaptic responses to spontaneous release of individual glutamate vesicles (Fig. 3c,d ). We did not observe a statistically significant difference in mEPSC amplitude in Tg2576 (12.77 ± 0.66) with respect to wild-type (14.12 ± 0.68, P > 0.05) mice, although a trend toward a decrease was apparent (Fig. 3d) . We did, however, observe that mEPSC frequency was significantly decreased in Tg2576 mice (wild type, 1.15 ± 0.14; Tg2576, 0.80 ± 0.09; P = 0.04; Fig. 3d) . A lack of PPR alterations, together with a reduction of mEPSC frequency, is consistent with a decrease in the number of AMPAR-containing synapses. These results are consistent with the reduction of GluR1 levels in the PSD and a loss of spines that we observed in 3-month-old Tg2576 mice, although we cannot exclude additional NMDAR alterations. 
a r t I C l e S
The role of GluR1 phosphorylation in synaptic plasticity, including long-term potentiation (LTP) and LTD, has been extensively studied 23 . We therefore tested whether the specific reduction of GluR1pSer845 in the PSD affected LTP and LTD expression. Similar levels of synaptic potentiation were observed in wild-type and Tg2576 mice (Fig. 3e) . This result suggests that the mechanisms of GluR1 trafficking to the PSD during LTP are still intact in Tg2576 mice at this age, as was found previously 24 . In contrast, we found that the magnitude of LTD observed in Tg2576 mice was slightly, but significantly, enhanced compared with wild-type mice ( P = 0.019; Fig. 3f ). These data suggest that the mechanisms driving synaptic depression, including specific dephosphorylation of GluR1Ser845, are more efficient in Tg2576 than in wild-type mice 25 .
Active caspase-3 increases in Tg2576 hippocampal synapses
In vitro studies have suggested that a localized caspase-3-dependent apoptosis contributes to early synaptic loss in Alzheimer and other neurodegenerative diseases 10 ; the mechanism(s) underlying this process, however, remains elusive. We examined whether caspase-3 activity was responsible for the observed PSD alteration and spine loss in the Tg2576 hippocampus. We compared caspase-3-like activity in wholecell extracts and synaptosomal fraction prepared from hippocampi of 2-and 3-month-old wild-type and Tg2576 mice. A substantial increase in caspase-3 activity, in both total hippocampal homogenates and synaptosomes, was observed in Tg2576 mice at 3, but not at 2, months of age (Fig. 4a ). An increase in caspase-3 activity was also detected in Tg2576-derived synaptosomes when compared with those from age-matched wild-type mice at 6 and 18 months after birth (Supplementary Fig. 5 ).
The cleaved forms of caspase-3 were detected in synaptosomes and we found a stronger immunoreactivity in synaptosomes from 3-month-old Tg2576 mice when compared with wild type (Fig. 4b) . Notably, we found that procaspase-3 was also more abundant in the synaptosomal fraction when compared with the total homogenate. These findings suggest that caspase-3 is preferentially localized and selectively activated in the synaptic compartment, whereas the other effector caspases (caspase-7 and caspase-6) remain uncleaved ( Supplementary Fig. 6 ).
To provide additional evidence of the synaptic localization of active caspase-3 in the hippocampus, we performed pre-embedding immunoelectron microscopy using an antibody specific to cleaved caspase-3. Immunostained spines were more abundant in Tg2576 neurons than in their wild-type counterparts ( Fig. 4c and Supplementary Fig. 7 ). In the spine, the immunoprecipitates were specifically concentrated in the PSD. No immunoreactivity was found in cell soma, nuclei, presynaptic terminals or surrounding glial projections.
The exposure of phosphatidylserine residue on the plasma membrane is usually considered to be a downstream event of caspase-3 activation and a hallmark of apoptosis 26 . To examine apoptosis in hippocampal synapses, we analyzed the exposure of phophatidylserine in the synaptosomal fraction in which active caspase-3 accumulated. By labeling with annexin V and a viability marker (calcein AM) before flow cytometry, we were able to measure local synaptic death in intact synaptosomes prepared from the hippocampus of 3-month-old wildtype and Tg2576 mice. We found that phophatidylserine exposure was increased in Tg2576-derived synaptosomes when compared with wild type (Fig. 4d) . The absence of genotype-dependent difference in a r t I C l e S propidium iodide labeling of hippocampal cell nuclei, isolated from the same hippocampi used for synaptosome preparation, rules out the possibility of widespread neuronal apoptosis (Fig. 4e) . The reported ~5% of nuclei incorporating propidium iodide is merely a result of the experimental procedure (background; unstained controls are shown in Supplementary Fig. 8a,b) . Consistent with these results, no cell death was detected by TUNEL assay in wild-type or Tg2576 hippocampi (Supplementary Fig. 8c ).
An increase in caspase-3 activity in the absence of neuronal death suggests a sublethal mitochondrial stress. This is consistent with the finding that, in the hippocampus of 3-month-old Tg2576 mice, protein oxidation level was higher than in those from age-matched controls (Supplementary Fig. 9 ). Comprehensively, these data indicate that oxidative stress is initiated in Tg2576 mice by 3 months of age, synchronous with the occurrence of some apoptotic biochemical features that can occur locally at the synapses.
The canonical activation of caspase-3 occurs in a wide range of cellular and in vivo systems by means of two main pathways 27, 28 : the extrinsic pathway of cell death, mediated by the death receptor family, and the mitochondrial (intrinsic) pathway of cell death, mediated by the Apaf1-centered apoptosome. As neuronal death usually follows the mitochondrion/apoptosome pathway, we expected caspase-3 to be activated via the intrinsic pathway. To confirm the involvement of the Apaf1-centered apoptosome in this context, we used Tg2576-derived primary hippocampal cultured neurons lacking Apaf1 (Tg + ; Apaf1 −/− double mutants). In both total lysates and synaptosomes from Tg + ; Apaf1 −/− neurons, we did not observe caspase-3 cleavage (Supplementary Fig. 10a,b) . In addition, in Tg + ; Apaf1 +/+ and Tg + ; Apaf1 −/− neurons, caspase-7 and caspase-6 were not activated (Supplementary Fig. 10c ). These results suggest that caspase-3 activation is apoptosome dependent in Tg2576 neurons.
Caspase-3 mediates GluR1 removal from postsynaptic sites As caspase-3 activity was increased in the postsynaptic compartments and synaptic GluR1 trafficking was altered in Tg2576 hippocampal neurons, we tested whether these two molecules interacted epistatically. We performed direct fluorimetric measurement of caspase-3-like activity in acute hippocampal slices from 3-month-old Tg2576 mice after 2 h of incubation with the caspase-3 inhibitor z-DEVD-fmk and found that z-DEVD-fmk inhibited caspase-3-like activity in a concentration-dependent manner (Fig. 5a) . Notably, cleaved PARP (a nuclear substrate of caspase-3) was undetectable in all experimental conditions, ruling out the possibility that z-DEVD-fmk protects neurons from cell death induced by slicing and incubation conditions (Supplementary Fig. 11 ).
Immunoblot analysis of PSD from Tg2576 slices treated with z-DEVD-fmk showed an increase of GluR1 and GluR1pSer845, as compared with the vehicle-treated controls. In contrast, caspase-3 inhibition had no effect on NMDAR subunits and PSD-95 levels (Fig. 5b) . A linear regression analysis showed that the GluR1 levels in the PSD were inversely correlated to caspase-3-like activity (Fig. 5c) . Conversely, analysis of PSD from wild-type slices treated with z-DEVD-fmk revealed that caspase-3 inhibition had an inverse effect on GluR1 surface expression (Supplementary Fig. 12 ). We also analyzed the content of GluR1 in total homogenate of Tg2576 hippocampal slices treated with z-DEVD-fmk and untreated slices. Caspase-3 inhibition caused an increase of GluR1pSer845, but there was no difference in total GluR1 levels (Fig. 5d) . 
a r t I C l e S
The treatment of Tg2576 hippocampal slices with the caspase negative control inhibiting other proteases, z-FA-fmk, caused an expected reduction of cathepsin B activity, but it did not affect the phosphorylation of GluR1 (Supplementary Fig. 13a,b) . These results indicate that caspase-3, under these experimental conditions, is specifically involved in GluR1 phosphorylation and mobility but not degradation.
To confirm the involvement of caspase-3 in the regulation of synaptic transmission, we measured the AMPA/NMDA ratio of CA1 neurons in acute Tg2576 hippocampal slices after 2 h of incubation with caspase-3 inhibitor or vehicle. We found that the AMPA/NMDA ratio in z-DEVD-fmk-treated slices was increased with respect to vehicle-incubated slices, restoring the ratio to the wild-type value (vehicle control, 19.46 ± 2.77; z-DEVD-fmk, 46.43 ± 8.48; wild type, 39. 34 ± 6.76; Fig. 5e) . The PPRs of synaptic responses did not differ in z-DEVD-fmk-treated and vehicle-treated slices (vehicle control, 1.34 ± 0.05; z-DEVD-fmk, 1.32 ± 0.05; wild type, 1.40 ± 0.07; Fig. 5f ), indicating that caspase-3 inhibition does not affect presynaptic release properties. These data suggest that blocking caspase-3 activity in Tg2576 neurons is sufficient to specifically restore postsynaptic glutamate transmission to wild-type levels.
Because calcineurin is required for Aβ-mediated synaptic removal of AMPAR, leading to loss of dendritic spines 29 , and calcineurin A (CN-A) is known to be proteolytically activated by caspase-3 (ref. 30) , we hypothesized that hippocampal CN-A activity would increase caspase-3 cleavage, inducing GluR1 removal from the PSD. To test whether CN-A is a hippocampal caspase-3 substrate, we performed an immunoblot analysis of the total homogenate from Tg2576 slices treated with z-DEVD-fmk or the vehicle control using an antibody specific to the N-terminal of CN-A. We found that CN-A processing was reduced in Tg2576 slices treated with z-DEVD-fmk (Fig. 6a) . Given that the 45-kDa CN-A fragment produced by caspase-3 cleavage contains the whole catalytic domain, but lacks the autoinhibitory one, we assayed CN-A activity in response to caspase-3 inhibition. We measured CN-A activity in a calcium-free medium to exclude a calcium-dependent regulation of CN-A activation. In addition, the specificity of the activity assay was confirmed using the calcineurin inhibitor FK506 (Fig. 6b) . We observed a reduction of calcium-independent CN-A activity in z-DEVD-fmk-treated slices as compared with vehicle-treated slices, indicating that caspase-3-dependent cleavage of CN-A causes its activation.
To confirm the effect of calcineurin activity on GluR1 phosphorylation, we also analyzed Tg2576 hippocampal slices treated with FK506 and compared them with untreated slices. Incubation with calcineurin inhibitor for 2 h increased GluR1pSer845 levels, but no differences were observed in total GluR1 from Tg2576 slices compared with vehicle-treated controls (Supplementary Fig. 14) . 
In addition, caspase-3 activity increase in 3-month-old Tg2576 hippocampus was associated in vivo with an increase of both activity and processing of calcineurin when compared with wild type (Supplementary Fig. 15a,b) . The levels of active calpain-1 were similar in young wild-type and Tg2576 mice, although an increase of calpain-1 cleavage was observed in older mice ( Supplementary  Fig. 15c ). This result excludes the involvement of calpain-1 in CN-A processing at this very early stage of disease in the Tg2576 mouse model. Taken together, these results suggest that caspase-3 is involved in GluR1 synaptic removal via CN-A cleavage.
Caspase-3 inhibition in vivo rescues Tg2576 phenotype We next addressed the possibility of rescuing GluR1 PSD levels, spine size and memory deficits by inhibiting caspase-3 in vivo. Because z-DEVD-fmk cannot cross the blood brain barrier and to minimize the pharmacological effect on other brain regions, we injected z-DEVD-fmk directly into one hippocampus and injected the vehicle into the contralateral hippocampus as a control. Caspase-3 and calcineurin activity and calcineurin processing were reduced 15 h after injection in the ipsilateral z-DEVD-fmk-injected side, as compared with the contralateral vehicle-injected hippocampus (Fig. 7a,b) . We analyzed the synaptic GluR1 content and found a marked translocation of GluR1 from the microsomal fraction to the PSD (Fig. 7c) , together with an increase of GluR1pSer845 in the PSD (Supplementary Fig. 16 ). To confirm the effect of caspase-3 inhibition on GluR1 synaptic distribution, we used the polyglutamic acid peptoid QM56 to inhibit the activity of the apoptosome 31 , a macromolecular complex that activates caspase-3 and the mitochondrial-dependent apoptosis pathway 32 .
We analyzed caspase-3 activity and GluR1 PSD levels 48 h after QM56 intra-hippocampal injection. We observed a reduction of caspase-3 activity in the ipsilateral QM56-injected side, as compared with the contralateral vehicle-injected hippocampus (Supplementary Fig. 17a) , and a marked translocation of GluR1 from the microsomal fraction to the PSD, with an increase of GluR1pSer845 in the PSD (Supplementary Fig. 17b,c) .
As we previously found that the DAPT injection in the hippocampus affected GluR1 synaptic distribution (Supplementary Fig. 3) , we also assessed whether this effect was mediated by caspase-3 by analyzing caspase-3 activity in Tg2576 hippocampus 15 h after DAPT injection. We observed a reduction of caspase-3 activity in the ipsilateral DAPT-injected side, as compared with the contralateral vehicleinjected hippocampus (Supplementary Fig. 18 ). Taken together, these results show the specificity of caspase-3 inhibition on synaptic function and indicate that the main route of caspase-3 activation is mitochondria dependent.
We also found that the head diameter of dendritic spines was enlarged in the ipsilateral z-DEVD-fmk-injected side compared with the contralateral vehicle-injected hippocampus, restoring spine size to wild-type levels (Figs. 7d and 1c) . Finally, bilateral injection of z-DEVD-fmk in the hippocampus of Tg2576 mice 15 h before training in CFC appreciably rescued the memory deficits (Fig. 7e) without affecting motor activity (Supplementary Fig. 19) . Notably, intrahippocampal injection of z-DEVD-fmk had an inverse effect on wild-type mice, confirming that caspase-3 is involved in hippocampal function. Specifically, synaptic fractionation of z-DEVD-fmk-treated wild-type hippocampi revealed a reduction of GluR1 at PSD compared with vehicle controls (Supplementary Fig. 20) . Moreover, z-DEVD-fmk-treated wild-type mice worsened memory in the CFC task (Fig. 7e) .
DISCUSSION
Caspase-3 activation is considered the terminal step in the biochemical cascade leading to apoptotic cell death 33 . However, the opinion that caspase-3 is more than just a 'killer' involved in neuronal programmed cell death is supported by studies implicating caspase-3 in regulation of synaptic plasticity [34] [35] [36] . Evidence for a role of caspase-3 in Alzheimer's disease includes caspase-3 activation in Aβ-treated neurons 37 , immunodetection of activated caspase-3 in the brains of individuals with Alzheimer's disease 38, 39 , involvement of caspase-3 in APP proteolysis and Aβ peptide formation 38 , and the increase of caspase-3 in the PSD fractions of individuals with Alzheimer's disease 40 . Despite this array of data indicating caspase-3 as an etiologic factor in Alzheimer's disease, the molecular mechanism(s) linking Alzheimer-related synaptic dysfunction to caspase-3 activity remains elusive.
Our results indicate that local upregulation of caspase-3 in hippocampal CA1 dendritic spines is important for triggering functional and structural hippocampal synaptic alterations correlating with the onset of memory deficits in the APPswe Tg2576 mouse model. Our combined ex vivo and in vivo analyses provide strong evidence that Tg2576 mice display enhanced caspase-3 activity in dendritic spines, resulting in a downregulation of the surface expression of GluR1-containing AMPAR via proteolytic activation of calcineurin. The alterations of PSD composition are accompanied by synaptic transmission deficits, enhanced LTD, and reduced spine size and density. These data are supported by the previous finding that synaptic AMPAR removal is both necessary and sufficient for Aβ-induced spine loss 31 . The existence of this non-apoptotic caspase-3-dependent mechanism at the onset of Alzheimer neurodegeneration is supported by the results of our ex vivo and in vivo rescue experiments using the caspase-3 inhibitor z-DEVD-fmk. Indeed, we found that caspase-3 inhibition restored glutamatergic synaptic transmission in Tg2576 slices to wild-type levels and that a single injection of caspase-3 inhibitor was sufficient to downregulate caspase-3 and calcineurin activity in vivo, thus restoring GluR1 levels at PSD, as well as spine size and memory performance. The pharmacological approach that we used allowed us to acutely reduce caspase-3 activity at the onset of Alzheimer-related cognitive decline in the Tg2576 mouse model. Indeed, this approach avoids any interference with developmental parameters, postnatal differentiation and neuron physiology that could be perturbed by genetic approaches, as highlighted by abnormal brain development in knockout mice with an altered caspase-3 activation [41] [42] [43] [44] .
Our data strongly support the possibility of targeting caspase-3 activity to reverse hippocampal function deficits at the onset of Alzheimer pathology. Nevertheless, the opposite effects produced by in vivo injection of the caspase-3 inhibitor in wild-type mice suggest that therapeutic intervention should take into account the critical physiological role of caspase-3-dependent proteolysis in synaptic plasticity and memory, independent of its role in apoptosis.
Our results suggest a model of the role of caspase-3 in dendritic spine degeneration (Supplementary Fig. 21 ). Intraneuronal accumulation of Aβ in distal processes and the synaptic compartment 45 leads to the generation of free radicals 46 . These reactive species in turn disrupt the electron transport chain, leading to mitochondrial dysfunction and consequent cytochrome c release from the outer membrane. The release of cytochrome c into the cytosol induces the formation of the apoptosome, which in turn recruits and activates caspase-3. Proteolytic cleavage of calcineurin induces a loss of its calcium-calmodulin sensitivity 32 . This causes an increase in its phosphatase activity, resulting in increased dephosphorylation of GluR1 at Ser845, followed by AMPAR removal from PSD and progressive spine loss. However, the cleavage of other synaptic substrates by caspase-3 cannot be excluded. Consistent with our model, recent evidence has suggested that the mitochondria are important organelles for Aβ-induced dendritic spine loss and neuronal damage 47 . We propose a mechanism a r t I C l e S downstream of mitochondrial dysfunction that orchestrates dendritic spine shrinkage and loss during early Alzheimer-related neurodegeneration. In conclusion, this mechanism suggests that caspase-3 can be used as an early biomarker of Alzheimer's disease and should encourage further studies on its regulation to develop rationale synaptoprotective therapies for preventing or slowing down Alzheimer's disease progression.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/. cFc. After 4 d of handling, each mouse was placed in the conditioning chamber (transparent Plexiglass cage, 28 × 28 × 10 cm) for 120 s of free exploration, followed by a series of five nonsignaled foot shocks (0.7 mA, 2-s duration, separated by 60-s intervals) delivered through the grid floor. CFC was assessed 24 h later by returning mice for 5 min to the conditioning chamber and not delivering a foot shock. Fear memory was estimated by recording the time spent in freezing behavior, defined as the total absence of all but respiratory movements associated with a crouching posture. Mice behavior was videotaped by means of a video camera connected to a computer equipped with dedicated software (Noldus Ethovision System, The Netherlands). Motor activity during the free exploration period was automatically scored using the Noldus Ethovision system. golgi cox staining and dendritic spine measurements. Naive male mice were intracardially perfused with 0.9% saline solution. The brains were impregnated by immersion in a standard Golgi-Cox solution (1% potassium dichromate (wt/vol), 1% mercuric chloride (wt/vol) and 0.8% potassium chromate (wt/vol)) for 6 d, transferred to a 30% sucrose solution (wt/vol) for 2 d, and then sectioned coronally (100 µm). Sections were mounted on gelatinized slides and stained according to the Gibb and Kolb method. Fully impregnated pyramidal neurons laying in the CA1 region of the dorsal hippocampus were identified under low magnification (20×/0.5 NA). In each brain, 11 neurons displaying dendritic tree without obvious truncations and balanced per hemisphere were analyzed under higher magnification (63×/0.75 NA). Measurements were carried out using a microscope (DMLB, Leica) equipped with a camera (resolution = 2,600 × 2,600, Axiocam, Zeiss), and the KS300 3.0 system (Zeiss). A computer-based neuron tracing system (Neurolucida, Microbrightfield) was used to trace single neurons. Spine density was assessed by counting the number of spines in five 20-µm dendrite segments per neuron chosen in branch orders 2-4 of apical and basal dendrites. All protrusions, with or without bulbous expansion, but no longer than 2 µm, were counted as spines if they were continuous with the dendritic shaft. The average spine density (number of spines per 1-µm-long segment) was averaged for a neuron mean. To determine dendritic spine morphology, we acquired the spines on five 20-µm apical dendrite segments per neuron under higher magnification (100×/1.25 NA) using a digital camera (Axiocam, Zeiss). Morphology was estimated by measuring spine head diameter using ImageJ (http://rsbweb. nih.gov/ij/). Values were averaged for neuron and cumulative frequencies compared among groups. Total dendrite length was automatically calculated by the Neurolucida software after each neuron was traced.
In vitro slice preparation and electrophysiology. Hippocampal slices were prepared as described previously 48 . Slices were recorded at 32 ± 1 °C in oxygenated artificial cerebrospinal fluid (aCSF) containing 126 mM NaCl, 26 mM NaHCO 3 , 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM MgSO 4 , 2 mM CaCl 2 and 10 mM glucose, gassed with 95% O 2 /5% CO 2 , pH 7.4, in the continuous presence of 100 µM picrotoxin. fEPSPs were recorded in the stratum radiatum of the CA1 and stimuli delivered by a monopolar electrode. Input/output relationships were generated by calculating the fEPSP initial slope (to avoid population spike contamination) corresponding to a given fiber volley amplitude (100 mV to 200 mV in increments of 50 mV). For LTP experiments, fEPSPs were stimulated at 0.1 Hz and LTP was induced by 1 train of 100 stimuli at 100 Hz. For LTD, slices were superfused with aCSF containing 4 mM Ca 2+ and LTD was induced with a low-frequency stimulation protocol of 900 pulses at 1 Hz.
Whole-cell patch-clamp recordings were obtained from CA1 pyramidal cells as described previously 48 . Recordings were made using intracellular solution (117.5 mM CsMeSO 4 , 15.5 mM CsCl, 10 mM TEACl, 8 mM NaCl, 1.25 mM NaH 2 PO 4 , 10 mM HEPES, 0.25 mM EGTA, 4 mM MgATP, 0.3 mM NaGTP, pH = 7.3, osmolarity ~290 mOsm). Series (10-20 MΩ) and input (100-200 MΩ) resistances were monitored online throughout each experiment. For the AMPAR/NMDAR ratio, cells were held at -65 mV to record AMPAR mediated currents and at +20 mV to record AMPAR-and NMDAR-mediated currents. The AMPAR EPSC amplitude was calculated at the peak (averaged over a 1-ms window) and the NMDA EPSC amplitude was calculated by measuring the current (2-ms window) at 60 ms after stimulation artifact. For PPR measurements, two pulses were delivered 100 ms apart at -65 mV. Spontaneous AMPAR-mediated mEPSCs were recorded at -65 mV holding potential in 4 mM external Ca 2+ and 7 mM external K + , in the presence of 0.5 µM tetrodoxin (Latoxan) and 100 µM picrotoxin (Sigma-Aldrich). Spontaneous events were analyzed using the Clampfit software (Molecular Devices) through a template search with variable amplitude.
For the experiments shown in Figure 5 , slices were incubated for 2 h with 5 µM z-DEVD-fmk at 20-25 °C and then transferred to the recording chamber. Only cells successfully recorded in 1 h of the end of incubation were included for analysis.
Surgical procedures. Mice were anesthetized with chloral hydrate (400 mg per kg) and mounted on stereotaxic apparatus. Bilateral injecting cannulae were inserted into the hippocampus (coordinates relative to bregma: anteroposterior, -2 mm; lateral, ±1.7 mm; ventral, 1.9 mm). Injections were performed using a 10 µl Hamilton syringe connected to a gauge injector.
One group of mice was injected in one hemi-hippocampus with 1 µl of 174 µM z-DEVD-fmk-DMSO solution (Imgenex) diluted in aCSF. As control, 1 µl of aCSF-DMSO solution was injected in the contralateral hemi-hippocampus. A separate group of mice was injected with 1 µl of 3.5 mM DAPT in one hemihippocampus and 1 µl of DMSO in the contralateral hemi-hippocampus. Another group of mice was injected with 1 µl of 0.7 mM QM56 (kindly provided by E. Pérez-Payá, Instituto de Biomedicina de Valencia and Centro de Investigacion Principe Felipe) diluted in phosphate-buffered saline (PBS). As a control, 1 µl of PBS was injected into the contralateral hemi-hippocampus. Injections of inhibitor or vehicle were balanced for hemispheres. Mice were killed 15 h (z-DEVD-fmkand DAPT-injected mice) and 48 h (QM56-injected mice) after the injections for brains collection. Two independent groups of naive mice were injected bilaterally in the hippocampus with either z-DEVD-fmk or DAPT 15 h before training in CFC task. Relative controls were injected with vehicle solutions.
PSd preparation. The brain was rapidly dissected and the hippocampus was homogenized in homogenization buffer (320 mM sucrose, 1 mM HEPES (pH 7.4), 1 mM MgCl 2 , 1 mM EDTA, 1 mM NaHCO 3 , 1 mM PMSF, 1 mM Na 3 VO 4 , 20 mM β-glycerophosphate, 5mM NaF, with protease inhibitors; Sigma) with ten strokes of a tight-fitting glass Dounce tissue grinder (7 ml, Wheaton). The homogenate was centrifuged at 1,000g for 10 min and the resulting supernatant was centrifuged at 3,000g for 15 min. The pellet was resuspended in 1 mM HEPES (pH 7.4) containing protease inhibitors and centrifuged at 100,000g for 1 h. The resulting pellet was resuspended in a buffer containing 75 mM KCl, 1% Triton X-100 (vol/vol) and proteases inhibitors and centrifuged at 100,000g for 1 h. The supernatant was referred to as the Triton X-100 soluble fraction. The pellet containing the PSD fraction (Triton X-100 insoluble fraction) was resuspended in RIPA buffer (50 mM Tris-HCl (pH 7.4), 1% Triton X-100, 0.25% sodium deoxycholate, (wt/vol) 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA, 0.1% SDS (wt/vol), protease inhibitors), sonicated and incubated on ice for 20 min. The samples were centrifuged at 11,500g for 10 min and the protein concentration of resulting supernatant was determined.
Subsynaptic fractionation. Hippocampus was homogenized in homogenization buffer (320 mM sucrose, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 mM NaHCO 3 , 1 mM PMSF, 1 mM Na 3 VO 4 , 5 mM NaF, protease inhibitors) with ten strokes of a tight-fitting glass Dounce tissue grinder. The homogenate was centrifuged at 1,000g for 10 min and the resulting supernatant was centrifuged at 10,000g for 15 min. Both the pellet and the supernatant were stored. The pellet was resuspended in homogenization buffer, incubated 40 min on ice and centrifuged at 32,000g for 20 min. The resulting pellet (TxP) containing PSDs was processed for protein extraction. The supernatant was centrifuged at 100,000g for 1 h and the microsomal-enriched proteins were extracted from the resulting pellet.
Synaptosome preparation. Hippocampus was homogenized in homogenization buffer (320 mM sucrose, 4 mM HEPES (pH 7.4), 1 mM EGTA, 1 mM PMSF, protease inhibitors) with ten strokes of a tight-fitting glass Dounce tissue grinder. The homogenate was centrifuged at 1,000g for 10 min and the resulting supernatant was centrifuged at 12,000g for 15 min. The pellet was resuspended in homogenization buffer and centrifuged at 13,000g for 15 min to obtain the final pellet containing the synaptosome-enriched fraction.
